Clinical Profiles Differ in IgG4-related Disease with and Without Allergy: a Large Case-Control Study in China

Zhen Zhao,Yanging Liu,Mingxin Bai,Qiaozhu Zeng,Zhenfan Wang,Da Chen,Zhanguo Li,Yin Su

DOI: https://doi.org/10.55563/clinexprheumatol/3l5o9u

2023-01-01

Clinical and Experimental Rheumatology

Abstract:Objective This study aimed to elucidate different clinical profiles in IgG4-related disease (IgG4-RD) with and without allergy. Methods Four hundred and thirty-four patients diagnosed with IgG4-RD at Peking University People's Hospital were included. Clinical and treatment options-based relapse data were collected and compared between IgG4-RD patients with and without allergy. Results Among these patients, 214 (49.3%) had allergic diseases. Most of the IgG4-RD patients with allergy had initial involved organs directly exposed to ambient air and their allergic symptoms occurred mostly before or at IgG4-RD disease onset. Compared with IgG4-RD patients without allergy, allergic patients had almost equal sex ratio, more organ involvement, earlier ages of disease onset and diagnosis, longer disease duration, higher incidence of dacryoadenitis, sialadenitis, lymphadenopathy, paranasal sinus and lung lesions. Higher serum IgG4, IgE and IgG4/IgG ratio, lower serum C3 complement 3 (C3) and C4, and higher incidence of eosinophilia were also found in IgG4- RD patients with allergy. Furthermore, allergy may increase relapse rate and shorten relapse-free survival time in IgG4-RD patients treated with glucocorticoids only, whereas combination therapy of glucocorticoids and immunosuppressants could improve treatment outcome. Conclusion Allergy leads to disparities in clinical profiles in IgG4-RD patients. Allergy could result in higher relapse rate and shorten relapse-free survival time in patients receiving glucocorticoids only.